INmune Bio (INMB) Short Interest Ratio & Short Volume → Like Tiny Crypto Retirement Funds (From Crypto 101 Media) (Ad) Free INMB Stock Alerts $11.02 -0.04 (-0.36%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media INmune Bio Short Interest DataCurrent Short Volume1,390,000 sharesPrevious Short Volume1,170,000 sharesChange Vs. Previous Month+18.80%Dollar Volume Sold Short$16.12 millionShort Interest Ratio / Days to Cover16.0Last Record DateFebruary 29, 2024Outstanding Shares18,020,000 sharesFloat Size11,730,000 sharesShort Percent of Float11.85%Today's Trading Volume80,772 sharesAverage Trading Volume79,969 sharesToday's Volume Vs. Average101% Short Selling INmune Bio ? Sign up to receive the latest short interest report for INmune Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINMB Short Interest Over TimeINMB Days to Cover Over TimeINMB Percentage of Float Shorted Over Time Ad Crypto 101 MediaLike Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. INmune Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20241,390,000 shares $16.12 million +18.8%11.9%16 $11.60 2/15/20241,170,000 shares $16.12 million No Change10.0%14.1 $13.78 1/31/20241,170,000 shares $13.96 million +3.5%10.0%16.2 $11.93 1/15/20241,130,000 shares $14.29 million +2.7%9.6%18.3 $12.65 12/31/20231,100,000 shares $12.39 million -3.5%9.4%19.2 $11.26 12/15/20231,140,000 shares $12.16 million -5.0%9.7%22.1 $10.67 Get the Latest News and Ratings for INMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. 11/30/20231,200,000 shares $11.34 million -0.8%11.5%27.1 $9.45 11/15/20231,210,000 shares $8.62 million -0.8%11.6%30.5 $7.12 10/31/20231,220,000 shares $8.89 million -4.7%11.7%32.2 $7.29 10/15/20231,280,000 shares $8.88 million +0.8%14.8%31.7 $6.94 9/30/20231,270,000 shares $8.60 million +13.4%13.1%22.3 $6.77 9/15/20231,120,000 shares $8.89 million -1.8%11.5%19.6 $7.94 8/31/20231,140,000 shares $9.23 million No Change9.7%20.6 $8.10 8/15/20231,140,000 shares $9.30 million No Change9.7%19.5 $8.16 7/31/20231,140,000 shares $9.77 million +3.6%9.7%18.5 $8.57 7/15/20231,100,000 shares $11.99 million No Change9.4%18.1 $10.90 6/30/20231,100,000 shares $9.99 million +4.8%9.4%24 $9.08 6/15/20231,050,000 shares $9.68 million +1.9%9.0%20.5 $9.22 5/31/20231,030,000 shares $7.81 million No Change8.8%20.3 $7.58 5/15/20231,030,000 shares $8.02 million No Change8.8%21.1 $7.79 4/30/20231,030,000 shares $7.47 million -1.9%8.8%20.2 $7.25 4/15/20231,050,000 shares $9.10 million -0.9%9.0%19 $8.67 3/31/20231,060,000 shares $6.85 million No Change9.1%17.7 $6.46 3/15/20231,060,000 shares $7.22 million -0.9%9.1%19 $6.81 2/28/20231,070,000 shares $10.10 million -0.9%9.2%19.5 $9.44 2/15/20231,080,000 shares $10.52 million No Change9.3%19.8 $9.74 1/31/20231,080,000 shares $9.27 million +9.4%9.3%19.9 $8.58 1/15/2023987,000 shares $8.73 million +4.4%8.5%20.4 $8.84 12/30/2022945,300 shares $5.99 million +3.5%8.1%21.1 $6.34 12/15/2022913,700 shares $6.86 million +2.8%7.8%20.7 $7.51 11/30/2022889,100 shares $6.36 million -2.3%7.6%19.2 $7.15 11/15/2022910,300 shares $7.10 million -3.1%7.8%19.1 $7.80 10/31/2022939,400 shares $7.21 million +2.3%8.1%19.4 $7.67 10/15/2022918,500 shares $5.69 million -0.5%7.9%17.1 $6.20 9/30/2022923,300 shares $5.72 million +3.5%7.9%16.8 $6.20 9/15/2022892,400 shares $7.32 million -9.9%7.7%14 $8.20 8/31/2022989,900 shares $7.99 million +2.2%8.5%15.3 $8.07 8/15/2022968,900 shares $8.88 million -1.1%8.3%9.4 $9.17 7/31/2022979,400 shares $8.79 million -3.0%8.4%8.8 $8.97 7/15/20221,010,000 shares $10.34 million -6.5%8.7%8 $10.248,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (Ad)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: Click to get the name of the cryptocurrency INMB Short Interest - Frequently Asked Questions What is INmune Bio's current short interest? Short interest is the volume of INmune Bio shares that have been sold short but have not yet been closed out or covered. As of February 29th, traders have sold 1,390,000 shares of INMB short. 11.85% of INmune Bio's shares are currently sold short. Learn More on INmune Bio's current short interest. What is a good short interest ratio for INmune Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INMB shares currently have a short interest ratio of 16.0. Learn More on INmune Bio's short interest ratio. Which institutional investors are shorting INmune Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of INmune Bio: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for INmune Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.85% of INmune Bio's floating shares are currently sold short. Is INmune Bio's short interest increasing or decreasing? INmune Bio saw a increase in short interest in the month of February. As of February 29th, there was short interest totaling 1,390,000 shares, an increase of 18.8% from the previous total of 1,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is INmune Bio's float size? INmune Bio currently has issued a total of 18,020,000 shares. Some of INmune Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. INmune Bio currently has a public float of 11,730,000 shares. How does INmune Bio's short interest compare to its competitors? 11.85% of INmune Bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to INmune Bio: Scilex Holding (7.28%), Omega Therapeutics, Inc. (18.22%), Innate Pharma S.A. (0.10%), Cardiff Oncology, Inc. (2.57%), Elevation Oncology, Inc. (9.07%), Graphite Bio, Inc. (2.56%), Black Diamond Therapeutics, Inc. (3.44%), Opthea Limited (0.21%), Solid Biosciences Inc. (2.12%), Acumen Pharmaceuticals, Inc. (1.86%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short INmune Bio stock? Short selling INMB is an investing strategy that aims to generate trading profit from INmune Bio as its price is falling. INMB shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against INmune Bio? A short squeeze for INmune Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INMB, which in turn drives the price of the stock up even further. How often is INmune Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INMB, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: SCLX Short Interest OMGA Short Interest IPHA Short Interest CRDF Short Interest ELEV Short Interest GRPH Short Interest BDTX Short Interest OPT Short Interest SLDB Short Interest ABOS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INMB) was last updated on 3/19/2024 by MarketBeat.com Staff From Our Partners8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin Analytics